These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 20804833

  • 1. Pro-IL-1β accumulation in macrophages by alendronate and its prevention by clodronate.
    Shikama Y, Nagai Y, Okada S, Oizumi T, Shimauchi H, Sugawara S, Endo Y.
    Toxicol Lett; 2010 Nov 30; 199(2):123-8. PubMed ID: 20804833
    [Abstract] [Full Text] [Related]

  • 2. Alendronate augments interleukin-1beta release from macrophages infected with periodontal pathogenic bacteria through activation of caspase-1.
    Deng X, Tamai R, Endo Y, Kiyoura Y.
    Toxicol Appl Pharmacol; 2009 Feb 15; 235(1):97-104. PubMed ID: 19063908
    [Abstract] [Full Text] [Related]

  • 3. Mutual augmentation of the induction of the histamine-forming enzyme, histidine decarboxylase, between alendronate and immuno-stimulants (IL-1, TNF, and LPS), and its prevention by clodronate.
    Deng X, Yu Z, Funayama H, Shoji N, Sasano T, Iwakura Y, Sugawara S, Endo Y.
    Toxicol Appl Pharmacol; 2006 May 15; 213(1):64-73. PubMed ID: 16203021
    [Abstract] [Full Text] [Related]

  • 4. Histidine decarboxylase-stimulating and inflammatory effects of alendronate in mice: involvement of mevalonate pathway, TNFalpha, macrophages, and T-cells.
    Deng X, Yu Z, Funayama H, Yamaguchi K, Sasano T, Sugawara S, Endo Y.
    Int Immunopharmacol; 2007 Feb 15; 7(2):152-61. PubMed ID: 17178381
    [Abstract] [Full Text] [Related]

  • 5. Necrotic actions of nitrogen-containing bisphosphonates and their inhibition by clodronate, a non-nitrogen-containing bisphosphonate in mice: potential for utilization of clodronate as a combination drug with a nitrogen-containing bisphosphonate.
    Oizumi T, Yamaguchi K, Funayama H, Kuroishi T, Kawamura H, Sugawara S, Endo Y.
    Basic Clin Pharmacol Toxicol; 2009 May 15; 104(5):384-92. PubMed ID: 19413658
    [Abstract] [Full Text] [Related]

  • 6. Comparative appraisal of clodronate, aspirin and dexamethasone as agents reducing alendronate-induced inflammation in a murine model.
    Yu Z, Funayama H, Deng X, Kuroishi T, Sasano T, Sugawara S, Endo Y.
    Basic Clin Pharmacol Toxicol; 2005 Oct 15; 97(4):222-9. PubMed ID: 16176557
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mouse macrophages primed with alendronate down-regulate monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha (MIP-1alpha) production in response to Toll-like receptor (TLR) 2 and TLR4 agonist via Smad3 activation.
    Masuda T, Deng X, Tamai R.
    Int Immunopharmacol; 2009 Aug 15; 9(9):1115-21. PubMed ID: 19501197
    [Abstract] [Full Text] [Related]

  • 9. Role of brain macrophages on IL-1beta and fatigue following eccentric exercise-induced muscle damage.
    Carmichael MD, Davis JM, Murphy EA, Carson JA, Van Rooijen N, Mayer E, Ghaffar A.
    Brain Behav Immun; 2010 May 15; 24(4):564-8. PubMed ID: 20051263
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of inflammatory and bone-resorption-inhibitory effects of alendronate by etidronate.
    Funayama H, Ohsako M, Monma Y, Mayanagi H, Sugawara S, Endo Y.
    Calcif Tissue Int; 2005 Jun 15; 76(6):448-57. PubMed ID: 15895282
    [Abstract] [Full Text] [Related]

  • 11. Augmentation of Lipopolysaccharide-Induced Production of IL-1α and IL-1β in Mice Given Intravenous Zoledronate (a Nitrogen-Containing Bisphosphonate) and Its Prevention by Clodronate (a Non-nitrogen-containing Bisphosphonate).
    Suzuki H, Bando K, Tada H, Kiyama T, Oizumi T, Funayama H, Sugawara S, Takahashi T, Endo Y.
    Biol Pharm Bull; 2019 Jun 15; 42(2):164-172. PubMed ID: 30713248
    [Abstract] [Full Text] [Related]

  • 12. Anti-inflammatory activity of PYNOD and its mechanism in humans and mice.
    Imamura R, Wang Y, Kinoshita T, Suzuki M, Noda T, Sagara J, Taniguchi S, Okamoto H, Suda T.
    J Immunol; 2010 May 15; 184(10):5874-84. PubMed ID: 20393137
    [Abstract] [Full Text] [Related]

  • 13. Contrasting effects of alendronate and clodronate on RAW 264 macrophages: the role of a bisphosphonate metabolite.
    Makkonen N, Salminen A, Rogers MJ, Frith JC, Urtti A, Azhayeva E, Mönkkönen J.
    Eur J Pharm Sci; 1999 May 15; 8(2):109-18. PubMed ID: 10210733
    [Abstract] [Full Text] [Related]

  • 14. Different effects of three bisphosphonates on nitric oxide production by RAW 264 macrophage-like cells in vitro.
    Makkonen N, Hirvonen MR, Teräväinen T, Savolainen K, Mönkkönen J.
    J Pharmacol Exp Ther; 1996 May 15; 277(2):1097-102. PubMed ID: 8627521
    [Abstract] [Full Text] [Related]

  • 15. Alendronate regulates cytokine production induced by lipid A through nuclear factor-κB and Smad3 activation in human gingival fibroblasts.
    Tamai R, Sugiyama A, Kiyoura Y.
    J Periodontal Res; 2011 Feb 15; 46(1):13-20. PubMed ID: 20663020
    [Abstract] [Full Text] [Related]

  • 16. Analgesic effects of the non-nitrogen-containing bisphosphonates etidronate and clodronate, independent of anti-resorptive effects on bone.
    Kim S, Seiryu M, Okada S, Kuroishi T, Takano-Yamamoto T, Sugawara S, Endo Y.
    Eur J Pharmacol; 2013 Jan 15; 699(1-3):14-22. PubMed ID: 23201069
    [Abstract] [Full Text] [Related]

  • 17. The activation of P2X7 receptor induces cathepsin D-dependent production of a 20-kDa form of IL-1β under acidic extracellular pH in LPS-primed microglial cells.
    Takenouchi T, Iwamaru Y, Sugama S, Tsukimoto M, Fujita M, Sekigawa A, Sekiyama K, Sato M, Kojima S, Conti B, Hashimoto M, Kitani H.
    J Neurochem; 2011 May 15; 117(4):712-23. PubMed ID: 21395581
    [Abstract] [Full Text] [Related]

  • 18. Nitric oxide prevents IL-1beta and IFN-gamma-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1beta-converting enzyme).
    Kim YM, Talanian RV, Li J, Billiar TR.
    J Immunol; 1998 Oct 15; 161(8):4122-8. PubMed ID: 9780184
    [Abstract] [Full Text] [Related]

  • 19. Involvement of cathepsin B in the processing and secretion of interleukin-1beta in chromogranin A-stimulated microglia.
    Terada K, Yamada J, Hayashi Y, Wu Z, Uchiyama Y, Peters C, Nakanishi H.
    Glia; 2010 Jan 01; 58(1):114-24. PubMed ID: 19544382
    [Abstract] [Full Text] [Related]

  • 20. Muramyldipeptide augments the actions of lipopolysaccharide in mice by stimulating macrophages to produce pro-IL-1β and by down-regulation of the suppressor of cytokine signaling 1 (SOCS1).
    Shikama Y, Kuroishi T, Nagai Y, Iwakura Y, Shimauchi H, Takada H, Sugawara S, Endo Y.
    Innate Immun; 2011 Feb 01; 17(1):3-15. PubMed ID: 19897531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.